Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation - PubMed (original) (raw)
. 1998 Feb 19;16(7):853-63.
doi: 10.1038/sj.onc.1201610.
Affiliations
- PMID: 9484776
- DOI: 10.1038/sj.onc.1201610
Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation
J Rodríguez-Villanueva et al. Oncogene. 1998.
Abstract
Nonmelanoma skin cancers (NMSC) are among the most common malignancies in the world. Typically, these neoplasms grow slowly and are comparatively indolent in their clinical behavior. The most frequent molecular alterations implicated in the pathogenesis of these neoplasms involve genes known to be regulators of cell death including p53, Ha-ras and bcl-2. In order to evaluate the significance cell death deregulation during skin carcinogenesis, we generated a transgenic mouse model (HK1.bcl-2) using the human keratin 1 promoter to target the expression of a human bcl-2 minigene to the epidermis. Transgenic HK1.bcl-2 protein was expressed at high levels specifically in the epidermis extending from the stratum basale through the stratum granulosum. The epidermis of HK1.bcl-2 mice exhibited multifocal hyperplasia without associated hyperkeratosis and aberrant expression of keratin 6. The rate of proliferation was similar in HK1.bcl-2 and control epidermis although suprabasal BrdUrd incorporating cells were present only in HK1.bcl-2 skin. Keratinocytes from the HK1.bcl-2 mice were significantly more resistant to cell death induction by U.V.-B, DMBA, and TPA, compared to control keratinocytes. Furthermore, papillomas developed at a significantly greater frequency and shorter latency in the HK1.bcl-2 mice compared to control littermates following initiation with DMBA and promotion with TPA. Together these results support a role for bcl-2 in the pathogenesis of NMSC.
Similar articles
- Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S, Chari NS, Kim HW, Wang X, Roop DR, Cho SH, DiGiovanni J, McDonnell TJ. Lee S, et al. Mol Carcinog. 2007 Dec;46(12):949-57. doi: 10.1002/mc.20334. Mol Carcinog. 2007. PMID: 17538944 - Transgenic models of skin diseases.
Rothnagel JA, Greenhalgh DA, Wang XJ, Sellheyer K, Bickenbach JR, Dominey AM, Roop DR. Rothnagel JA, et al. Arch Dermatol. 1993 Nov;129(11):1430-6. Arch Dermatol. 1993. PMID: 7694550 Review. - Multistage epidermal carcinogenesis in transgenic mice: cooperativity and paradox.
Greenhalgh DA, Wang XJ, Roop DR. Greenhalgh DA, et al. J Investig Dermatol Symp Proc. 1996 Apr;1(2):162-76. J Investig Dermatol Symp Proc. 1996. PMID: 9627712 Review.
Cited by
- Restrained Terminal Differentiation and Sustained Stemness in Neonatal Skin by Ha-Ras and Bcl-2.
Lee S, Rodriguez-Villanueva J, McDonnell T. Lee S, et al. Am J Dermatopathol. 2017 Mar;39(3):199-203. doi: 10.1097/DAD.0000000000000678. Am J Dermatopathol. 2017. PMID: 27655119 Free PMC article. - PLCε signaling in cancer.
Zhang RY, Du WQ, Zhang YC, Zheng JN, Pei DS. Zhang RY, et al. J Cancer Res Clin Oncol. 2016 Apr;142(4):715-22. doi: 10.1007/s00432-015-1999-x. Epub 2015 Jun 25. J Cancer Res Clin Oncol. 2016. PMID: 26109147 Review. - Interaction between the TP63 and SHH pathways is an important determinant of epidermal homeostasis.
Chari NS, Romano RA, Koster MI, Jaks V, Roop D, Flores ER, Teglund S, Sinha S, Gruber W, Aberger F, Medeiros LJ, Toftgard R, McDonnell TJ. Chari NS, et al. Cell Death Differ. 2013 Aug;20(8):1080-8. doi: 10.1038/cdd.2013.41. Epub 2013 May 17. Cell Death Differ. 2013. PMID: 23686138 Free PMC article. - Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of Bcl-2.
Han ME, Lee YS, Baek SY, Kim BS, Kim JB, Oh SO. Han ME, et al. Int J Mol Sci. 2009 Jul 6;10(7):3033-3043. doi: 10.3390/ijms10073033. Int J Mol Sci. 2009. PMID: 19742123 Free PMC article. - A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.
Torchia EC, Chen Y, Sheng H, Katayama H, Fitzpatrick J, Brinkley WR, Caulin C, Sen S, Roop DR. Torchia EC, et al. Cancer Res. 2009 Sep 15;69(18):7207-15. doi: 10.1158/0008-5472.CAN-09-1059. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous